EPHA2 and triple-negative breast carcinoma: Taken together, our results demonstrate that brucine inhibits the migration, invasion, and vasculogenic mimicry in human triple-negative breast cancer cell line MDA-MB-231, which might be through the disruption of cytoskeleton and downregulation of EphA2, MMP-9, and MMP-2.